Related Experiment Video
Updated: Aug 31, 2025

04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
892
Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules management
Domenico Albano1,2, Giorgio Treglia3,4,5, Francesco Dondi6
1Nuclear Medicine, ASST Spedali Civili Brescia, Brescia, Italy. domenico.albano@unibs.it.
Endocrine
|August 19, 2022
Summary
Total thyroidectomy (TT) and hemithyroidectomy (HT) are effective for TIR3B thyroid nodules, with a high malignancy rate of 48%. Surgical approach choice depends on risk factors, nodule size, and patient/surgeon considerations.
Area of Science:
- Endocrinology
- Surgical Oncology
- Pathology
Background:
- Thyroid nodules classified as TIR3B present a diagnostic challenge due to their potential for malignancy.
- Accurate risk stratification and appropriate surgical management are crucial for optimal patient outcomes.
Purpose of the Study:
- To compare the efficacy and safety of total thyroidectomy (TT) versus hemithyroidectomy (HT) in managing TIR3B thyroid nodules.
- To evaluate the rates of malignancy and post-surgical complications associated with each surgical approach.
Main Methods:
- A retrospective analysis of 136 patients diagnosed with TIR3B thyroid nodules between 2011 and 2019.
- Patients underwent either TT (106 cases) or HT (30 cases).
- Outcomes assessed included final histopathological diagnosis, malignancy rates, and post-surgical complications.
Main Results:
- A high malignancy rate of 48% was observed in the TIR3B cohort.
- Malignancy was significantly more frequent in the TT group (53%) compared to the HT group (30%) (p=0.001).
- Both TT and HT demonstrated low rates of post-surgical complications, with one case of transient hypocalcemia reported after TT.
Conclusions:
- The observed malignancy rate for TIR3B lesions is higher than anticipated.
- Both TT and HT are effective surgical options for TIR3B nodules, offering low complication rates.
- Decision-making for surgical approach should integrate clinical risk factors, nodule characteristics, patient preferences, and surgeon expertise.

